Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,196 shares at $133.01 ($292K) on 2024-02-13, disclosed to the SEC on 2024-02-15.
Scheduled sale ($292k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.01 | 1,098 | $146K | 50.0% |
| 2 | $133.01 | 1,098 | $146K | 50.0% |
| Total | $133.01 avg | 2,196 | $292K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |